Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Current Opinion in Hematology|January 10, 2015
Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromesNatasha Kekre, John KorethExpert Opinion on Emerging Drugs|March 24, 2016
Emerging drugs for graft-versus-host diseaseNatasha Kekre, Joseph H AntinBlood Advances|January 4, 2018
ATG in allogeneic stem cell transplantation: standard of care in 2017? CounterpointNatasha Kekre, Joseph H AntinSeminars in Hematology|March 23, 2016
Cord blood versus haploidentical stem cell transplantation for hematological malignanciesNatasha Kekre, Joseph H AntinBlood Reviews|September 29, 2018
Venous thromboembolism incidence in hematologic malignanciesNatasha Kekre, Jean M ConnorsAmerican Journal of Hematology|October 11, 2015
Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemiaNatasha Kekre, Vincent T HoBlood|June 11, 2014
Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not existNatasha Kekre, Joseph H AntinClinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
A Discussion with Dr. Natasha Kekre, Hematologist and Clinician ScientistAmelia T Yuan, Natasha KekreCancer Chemotherapy and Pharmacology|February 24, 2005
Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cellsNatasha Kekre, Carly Griffin, James McNulty, et al.Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|September 13, 2005
Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatinSiyaram Pandey, Natasha Kekre, Jafar Naderi, et al.Pageof 9